|
Wu, J., Song, Y., Su, L., Zu, L., Chen, T., Zhao, Z., Zhang, M., Li, W., Hu, Y., Zhang, X., Gao, Y., Niu, Z., Feng, R., Wang, W., Peng, J., Li, X., Ouyang, X., Wu. C., Zhang, W., Zeng, Y. Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study. BMC Cancer. 2016; 16(1): 537.
|